Inflammatory Biomarker Detection Increases Value in Early Drug Development
Inflammation is a key pathological driver in many neurological diseases. The interplay between the central and peripheral nervous systems and the...
Preclinical Discovery (3)
The HTX-011 Story
HTX-011 Breakthrough in Pain Management ZYNRELEF, the commercial name for HTX-011, is the first and only FDA-approved extended-release dual-acting...
Translating Preclinical Data to the Clinic
It's a question that comes up regularly, from scientists who contact us to publications to conference lectures. One of the challenges in preclinical...